Melanie Melissa Miranda, WHNP-BC is a
Nurse Practitioner - Women's Health based in Frontenac, Missouri. Melanie Melissa Miranda is licensed to practice in Missouri (license number 104388372) and her current practice location is
23 Clayton Ter, Frontenac, Missouri. She can be reached at her office (for appointments etc.) via phone at
(314) 608-6645.
NPI number for Melanie Melissa Miranda is 1811531395 and her current mailing address is 23 Clayton Ter, Frontenac, Missouri. She
does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1811531395.
Provider's Profile
Full Name | Melanie Melissa Miranda |
---|
Gender | Female |
---|
Speciality | Nurse Practitioner - Women's Health |
---|
Location | 23 Clayton Ter, Frontenac, Missouri |
---|
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
NPI Data:
- NPI Number: 1811531395
- Provider Enumeration Date: 10/29/2019
- Last Update Date: 10/29/2019
Medical Identifiers
Medical identifiers for Melanie Melissa Miranda such as npi, medicare ID, medicare PIN, medicaid, etc.
Identifier | Type | State | Issuer |
1811531395 | NPI | - | NPPES |
Medical Taxonomies and Licenses
Taxonomy | Type | License (State) | Status |
363LW0102X | Nurse Practitioner - Women's Health | 104388372 (Missouri) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Melanie Melissa Miranda is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
Mailing Address | Practice Location Address |
Melanie Melissa Miranda, WHNP-BC 23 Clayton Ter, Frontenac, MO 63131-2920 Ph: (314) 608-6645 | Melanie Melissa Miranda, WHNP-BC 23 Clayton Ter, Frontenac, MO 63131-2920 Ph: (314) 608-6645 |
Reviews and Comments